SAS and Ingenuity Systems have announced a partnership aimed at streamlining the discovery of important biological connections from high-throughput microarray experiments. Integration between JMP ...
Investing.com - JMP Securities has reiterated its Market Outperform rating and $90.00 price target on Crinetics (NASDAQ:CRNX) following new long-term safety and efficacy data for its lead drug ...
LONDON--(BUSINESS WIRE)--Rosslyn Analytics, the leader in cloud-based self-service spend data management solutions, has been recognized by JMP Securities, a full-service investment bank, as one of the ...
Investing.com - JMP Securities has reiterated its Market Outperform rating and $41.00 price target on Caesars Entertainment (NASDAQ:CZR) stock, according to a research note published Friday. The ...
Investing.com - JMP Securities maintained its Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ:LRMR) stock on Tuesday. According to InvestingPro data, analysts are ...
Investing.com - JMP Securities maintained its Market Outperform rating and $89.00 price target on Structure Therapeutics (NASDAQ:GPCR) Monday. According to InvestingPro data, analysts’ price targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback